These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23952191)

  • 1. Dopamine receptors and the pharmacogenetics of side-effects of stimulant treatment for attention-deficit/hyperactivity disorder.
    Levy F; Wimalaweera S; Moul C; Brennan J; Dadds MR
    J Child Adolesc Psychopharmacol; 2013 Aug; 23(6):423-5. PubMed ID: 23952191
    [No Abstract]   [Full Text] [Related]  

  • 2. The early development of child psychopharmacogenetics.
    Cook EH
    J Am Acad Child Adolesc Psychiatry; 1999 Dec; 38(12):1478-81. PubMed ID: 10596246
    [No Abstract]   [Full Text] [Related]  

  • 3. Update on Attention-Deficit/Hyperactivity Disorder.
    Soileau EJ
    Adolesc Med State Art Rev; 2014 Aug; 25(2):502-19. PubMed ID: 27132328
    [No Abstract]   [Full Text] [Related]  

  • 4. Does stimulant medication decrease the lower extremity response times of children with and without attention-deficit/hyperactivity disorder?
    Brasić JR
    Percept Mot Skills; 2007 Feb; 104(1):67-8. PubMed ID: 17450965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A two-part model of stimulant action on attention-deficit hyperactivity disorder in children.
    McCracken JT
    J Neuropsychiatry Clin Neurosci; 1991; 3(2):201-9. PubMed ID: 1687963
    [No Abstract]   [Full Text] [Related]  

  • 6. CNS stimulant controversies.
    Levy F
    Aust N Z J Psychiatry; 1989 Dec; 23(4):497-502. PubMed ID: 2575372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac safety of central nervous system stimulants in children and adolescents with attention-deficit/hyperactivity disorder.
    Winterstein AG; Gerhard T; Shuster J; Johnson M; Zito JM; Saidi A
    Pediatrics; 2007 Dec; 120(6):e1494-501. PubMed ID: 18055666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of stimulant treatment in attention deficit hyperactivity disorder: Part I.
    Merkel RL; Kuchibhatla A
    Expert Opin Drug Saf; 2009 Nov; 8(6):655-68. PubMed ID: 19785509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on long-term stimulant medication treatment of attention-deficit hyperactivity disorder.
    Barbaresi WJ
    J Dev Behav Pediatr; 2014 Sep; 35(7):446-7. PubMed ID: 25180894
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder.
    Wilens TE
    J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S46-53. PubMed ID: 18480677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulant side effects: prefrontal/basal ganglia circuit control at dopamine D1/D2 receptors.
    Levy F; Dadds MR
    Australas Psychiatry; 2014 Apr; 22(2):179-82. PubMed ID: 24425798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDA-approved drugs to treat ADHD.
    J Psychosoc Nurs Ment Health Serv; 2013 Mar; 51(3):11-2. PubMed ID: 23452016
    [No Abstract]   [Full Text] [Related]  

  • 13. Stimulant-drug therapy for attention-deficit disorder (with or without hyperactivity) and sudden cardiac death.
    Knight M
    Pediatrics; 2007 Jan; 119(1):154-5. PubMed ID: 17200281
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacotherapy in ADHD. Guidelines for prescribing stimulant medications in young children.
    August GJ; Realmuto GM
    Minn Med; 2000 Jun; 83(6):45-6. PubMed ID: 10881573
    [No Abstract]   [Full Text] [Related]  

  • 15. Methylphenidate (Ritalin) use and abuse.
    Crutchley A; Temlett JA
    S Afr Med J; 1999 Oct; 89(10):1076-9. PubMed ID: 10582063
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanism of action of agents used in attention-deficit/hyperactivity disorder.
    Wilens TE
    J Clin Psychiatry; 2006; 67 Suppl 8():32-8. PubMed ID: 16961428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic treatment of attention deficit hyperactivity disorder.
    Greenhill LL
    Psychiatr Clin North Am; 1992 Mar; 15(1):1-27. PubMed ID: 1347936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The run on Ritalin. Attention deficit disorder and stimulant treatment in the 1990s.
    Diller LH
    Hastings Cent Rep; 1996; 26(2):12-8. PubMed ID: 8722521
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of stimulant medications for ADHD.
    Natl Bur Econ Res Bull Aging Health; 2014; (1):1-2. PubMed ID: 25141389
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of a hyperactive teen and cardiac safety.
    Sowinski H; Karpawich PP
    Pediatr Clin North Am; 2014 Feb; 61(1):81-90. PubMed ID: 24267459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.